* Eikon search string for individual stock moves: STXBZ
* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi
* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh U.S. stocks opened at record-highs on Tuesday as oil prices rose and investors cheered strong results of top U.S. retailers.
The Dow Jones Industrial Average was up 0.45 percent at 20,716.37, the S&P 500 was up 0.43 percent at 2,361.21 and the Nasdaq Composite was up 0.40 percent at 5,861.8.
** KRAFT HEINZ CO, $93.48, -3.28 pct
** UNILEVER PLC, $44.42, -8.47 pct
** MONDELEZ INTERNATIONAL INC, $44.43, +4.53 pct
The U.S. food company’s rapid retreat from its surprise $143 billion bid for Unilever, in the face of stiff resistance knocked the Anglo-Dutch company’s shares on Friday as investors assessed the impact of the failed approach.
Oreo cookie maker Mondelez is rumored to be a Kraft acquisition target.
** POPEYES LOUISIANA KITCHEN INC, $78.80, +19.18 pct
Restaurant Brands International Inc, owner of the Burger King and Tim Hortons fast-food chains, said it would acquire Popeyes Louisiana Kitchen PLKI.O for $1.8 billion in cash.
** EYEGATE PHARMACEUTICALS INC, $2.57, +56.72 pct
** VALEANT PHARMACEUTICALS INC, $16.29, +1.56 pct
The eye drug developer entered a deal with Canadian drugmaker Valeant Pharmaceuticals Inc, which grants Valeant exclusive, worldwide commercial and manufacturing rights to its EyeGate II Delivery System and EGP-437 combination product candidate for use in post-operative treatment.
** TRONOX LTD, $17.96, +24.55 pct
The chemical maker said it would expand a business that makes titanium dioxide, a whitening pigment used in paints, paper and plastics with a $1.67 billion deal.
** WAL-MART STORES INC, $71.42, +2.96 pct
The retailer reported higher-than-expected global comparable sales, helped by a rise in online sales and higher traffic at Wal-Mart and Sam’s Club stores.
** MEDTRONIC PLC, $80.69, +2.29 pct
The medical device maker reported better-than-expected quarterly revenue and profit, driven by higher demand for its heart, vascular and minimally invasive products.
** INTERPACE DIAGNOSTICS GROUP INC, $2.95, +8.53 pct
The provider of molecular diagnostic tests and pathology services announced a deal with cancer dialysis company Viatar CTC Solutions Inc to help assess indeterminate pancreatic cancer biopsies in patients with pancreatic cysts.
** TREVENA INC, $4.68, -34.36 pct
The drug developer said only some doses of its experimental opioid painkiller were found as effective as morphine in two late-stage studies, even though the drug outperformed a placebo, meeting its main study goals.
** FREEPORT-MCMORAN INC, $14.10, -5.43 pct
The U.S. mining giant warned on Friday it could take the Indonesian government to arbitration and seek damages over a contractual dispute that has halted operations at the world’s second-biggest copper mine.
** AMPHASTAR PHARMACEUTICALS INC, $15.60, -15.24 pct
The drugmaker said the U.S. Food and Drug Administration rejected its application to market an intranasal version of the emergency opioid-overdose treatment, naloxone.
** BRISTOL-MYERS SQUIBB CO, $53.57, -1.87 pct
The drugmaker said it appointed three directors to its board in a deal with activist investor Jana Partners LLC.
** COMMUNITY HEALTH SYSTEMS INC, $8.99, +30.29 pct
Mizuho Securities USA raised the hospital operator’s rating to “neutral” from “underperform” and price target to $7.50 from $3.00, after the company forecast a “reasonable” 2017.
** CIDARA THERAPEUTICS INC, $6.79, -41.97 pct
The biotech company said a mid-stage data on its experimental topical antifungal drug was not effective enough to justify further development in patients with a type of vaginal yeast infection called acute vulvovaginal candidiasis.
** GENERAL MOTORS CO, $37.84, +1.67 pct
PSA Group, the maker of Peugeot and Citroen cars, will respect existing Opel and Vauxhall labor agreements if it buys the European arm of General Motors, PSA and Opel workers’ representatives said in a joint statement.
** DRYSHIPS INC, $3.25, -27.29 pct
The dry bulk shipper said it would sell up to $200 million of its shares to Kalani Investments Ltd.
Compiled by Vishaka George in Bengaluru; Edited by Martina D'Couto